Drugs Made In America Acquisition (DMAA) Return on Assets (2025)
Drugs Made In America Acquisition's (DMAA) quarterly Return on Assets came in at 0.0% in Q4 2025, up 2.69% on a QoQ basis from 0.0% in Q3 2025.
Drugs Made In America Acquisition (DMAA) Return on Assets (2025) Analysis & Trends
Drugs Made In America Acquisition (DMAA) has 1 years of Return on Assets data on file, last reported at 0.0% in Q4 2025.
- Quarterly Return on Assets changed N/A year-over-year to 0.0% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0% (changed N/A YoY) and the FY2025 annual result came in at 0.0%, changed N/A from the prior year.
- Return on Assets rose to 0.0% in Q4 2025, from 0.0% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.0% in Q4 2025 to a low of 0.0% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | 0.00% |
| 2 | Drugs Made In America Acquisition | 507.00 Mn | 507.00 Mn | - | 0.00% |
| 3 | Cantor Equity Partners IV | 467.55 Mn | 467.55 Mn | - | 0.00% |
| 4 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | 0.00% |
| 5 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | 0.00% |
| 6 | Gores Holdings X | 381.05 Mn | 380.85 Mn | - | 0.00% |
| 7 | Agriculture & Natural Solutions Acquisition | 377.29 Mn | 377.04 Mn | - | 0.00% |
| 8 | Blue Water Acquisition Corp. III | 342.12 Mn | 342.08 Mn | - | 0.00% |
| 9 | Berto Acquisition | 313.96 Mn | 313.81 Mn | - | 0.00% |
| 10 | Drugs Made In America Acquisition | 215.52 Mn | 215.52 Mn | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |